Zeke Capital Advisors, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History
Zeke Capital Advisors, LLC
- $1.53 Billion
- Q4 2022
A detailed history of Zeke Capital Advisors, LLC transactions in Eiger Bio Pharmaceuticals, Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 13,000 shares of EIGR stock, worth $164,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,000
Previous 35,500
63.38%
Holding current value
$164,450
Previous $267,000
94.38%
% of portfolio
0.0%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding EIGR
# of Institutions
6Shares Held
748KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY345KShares$4.36 Million0.64% of portfolio
-
Act Capital Management, LLC Wayne, PA235KShares$2.97 Million2.44% of portfolio
-
Drw Securities, L.L.C. Chicago, IL120KShares$1.52 Million0.02% of portfolio
-
Dfpg Investments, LLC32.4KShares$410,2390.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.25KShares$28,4620.0% of portfolio
About Eiger BioPharmaceuticals, Inc.
- Ticker EIGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,966,800
- Market Cap $556M
- Description
- Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...